The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to affirm a decision by the U.S. District Court for the District of Maryland in September to deny a preliminary injunction sought by drug companies and PhRMA against enforcement of Maryland's state law protecting 340B pricing for contract pharmacy arrangements.  

The AHA also filed amicus briefs in the district court in July and August, defending Maryland’s law against drug industry efforts to enjoin it.  

Others joining AHA in the Feb. 28 filing were 340B Health, the Maryland Hospital Association, the Mid-Atlantic Association of Community Health Centers and the American Society of Health-System Pharmacists. 

Related News Articles

Headline
A U.S. District Court for the District of Columbia judge June 27 ruled against Johnson & Johnson and sided with the Department of Health and Human Services…
Headline
The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater…
Chairperson's File
Public
Advocacy is such an important part of what we do as hospitals and health systems — and what the AHA does on behalf of our field — to help ensure that we get…
Headline
The AHA June 4 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee in defense of the state’s 340B contract pharmacy law…
Headline
The Department of Health and Human Services May 20 announced it has identified specific pricing targets for pharmaceutical manufacturers to meet to satisfy…
Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate…